Will Moderna report positive results for its children's vaccine before the end of March 2022?
Basic
13
Ṁ2438
resolved Apr 1
Resolved
YES
On January 12th, 2022, Moderna released a statement indicating that it expects to report data on its vaccine in children ages 2-5 in March, 2022. The statement can be found here: https://investors.modernatx.com/Statements--Perspectives/Statements--Perspectives-Details/2022/Statement-on-COVID-19-Vaccine-Clinical-Studies-in-Children--Adolescents/default.aspx This market will resolve to yes if Moderna releases a statement in or before March 2022 indicating that the result of it's trial was positive and that it intends to proceed with regulatory filings for children ages 2-5. Jan 13, 10:24pm: #Covid Apr 1, 9:04am: Resolving "yes" based on this statement: https://investors.modernatx.com/news/news-details/2022/Moderna-Announces-its-COVID-19-Vaccine-Phase-23-Study-in-Children-6-Months-to-Under-6-Years-Has-Successfully-Met-Its-Primary-Endpoint/default.aspx See in particular this line: "Moderna is moving forward with global regulatory submissions for mRNA-1273 for primary vaccination of children 6 months to under 6 years of age."
Get
Ṁ1,000
and
S3.00

Related questions

© Manifold Markets, Inc.•Terms + Mana-only Terms•Privacy•Rules